Manufacturers sound off on FDA drug reporting guidance, pointing to challenges and recommendations
In 2020, as a result of the CARES Act, drug manufacturers are now required to report new data annually to the FDA, including the amount …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
